Workflow
工程化外泌体
icon
Search documents
研判2025!中国外泌体行业分类、市场规模及重点企业分析:生物技术突破与细胞通讯机制解析推动外泌体技术革新,加速临床诊断与治疗范式升级[图]
Chan Ye Xin Xi Wang· 2025-09-08 01:05
Industry Overview - The exosome industry in China is experiencing strong growth, with a market size projected to reach 2.279 billion yuan in 2024, representing a year-on-year increase of 22.72% [1][7]. - Exosomes are membrane vesicles released from cells that play a crucial role in intercellular communication, containing various biomolecules such as proteins, lipids, and nucleic acids [2][6]. Industry Chain - The upstream of the exosome industry includes sources like animal, plant, and microbial exosomes, along with necessary biological reagents and production equipment [6]. - The midstream focuses on the production and manufacturing of exosomes, while the downstream applications span medical, aesthetic, and research services [6]. Key Applications - In the medical field, exosomes are utilized for tumor treatment by modulating the tumor microenvironment and delivering drugs [7]. - Exosomes serve as ideal biomarkers for liquid biopsies due to their high stability, enabling dynamic monitoring of tumor progression [7]. - In the aesthetic sector, exosomes are leveraged for anti-aging products due to their active components and low immunogenicity [7]. Market Size - The continuous advancement in biotechnology and exploration of intercellular communication mechanisms have led to significant developments in emerging technologies like engineered exosomes and microfluidics [1][11]. - The exosome market in China is projected to grow significantly, with a market size of 2.279 billion yuan expected in 2024, reflecting a 22.72% increase from the previous year [1][11]. Key Companies - Beijing Enze Kangtai Biotechnology Co., Ltd. has established a leading position in the engineered exosome sector with its GMP production facility and extensive collaborations [8]. - Guodian (Beijing) Pharmaceutical Technology Co., Ltd. focuses on innovative drug development using iPS cells and exosomes, particularly for neurological and immune-related diseases [9]. Industry Development Trends - Technological innovations are expected to enhance the efficiency and precision of exosome extraction, purification, and detection, facilitating large-scale production [11]. - The application of exosomes in disease diagnosis and treatment is anticipated to expand, with specific biomarkers being utilized for early diagnosis and therapeutic delivery [12]. - Increased government support and the establishment of industry standards will lead to stricter quality control and production practices in the exosome sector [13].